Literature DB >> 9367876

The monocyte chemotactic protein-4 induces oxygen radical production, actin reorganization, and CD11b up-regulation via a pertussis toxin-sensitive G-protein in human eosinophils.

K Tenscher1, B Metzner, C Hofmann, E Schöpf, J Norgauer.   

Abstract

The novel human CC-chemokine monocyte chemotactic protein-4 (MCP-4) is a chemotaxin for eosinophils. Here, the biological activities and the activation profile of MCP-4 was further characterized in eosinophils and compared to other activators such as platelet activating factor (PAF), Eotaxin and RANTES. As demonstrated by lucigenin-dependent chemiluminescence and superoxide dismutase-inhibitable cytochrome C reduction MCP-4 stimulated the production of reactive oxygen metabolites. Furthermore, MCP-4 induced up-regulation of the integrin CD11b. Flow cytometric studies revealed rapid and transient actin polymerization upon stimulation with MCP-4. At optimal concentrations the changes induced by MCP-4 were weaker than the effects after stimulation with PAF and comparable to those obtained by RANTES and Eotaxin. Cell responses elicited by MCP-4 were inhibited by pertussis toxin indicating involvement of Gi-proteins in this signal pathway. These findings point to a role of MCP-4 in the pathogenesis of eosinophilic inflammation as chemotaxin as well as activator of pro-inflammatory effector functions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9367876     DOI: 10.1006/bbrc.1997.7601

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Fractalkine-induced endothelial cell migration requires MAP kinase signaling.

Authors:  Michael V Volin; Nha Huynh; Karolina Klosowska; Rosemary D Reyes; James M Woods
Journal:  Pathobiology       Date:  2010-02-25       Impact factor: 4.342

2.  CDIP-2, a synthetic peptide derived from chemokine (C-C motif) ligand 13 (CCL13), ameliorates allergic airway inflammation.

Authors:  E Mendez-Enriquez; Y Melendez; F Martinez; G Baay; S Huerta-Yepez; C Gonzalez-Bonilla; T I Fortoul; G Soldevila; E A García-Zepeda
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

Review 3.  The multiple faces of CCL13 in immunity and inflammation.

Authors:  E Mendez-Enriquez; E A García-Zepeda
Journal:  Inflammopharmacology       Date:  2013-07-12       Impact factor: 4.473

Review 4.  Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease.

Authors:  Shaoping She; Liying Ren; Pu Chen; Mingyang Wang; Dongbo Chen; Ying Wang; Hongsong Chen
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.